Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Sheri

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Clinical Oncology (Royal College of Radiologists (Great Britain))|December 11, 2012
New developments and future directions in systemic therapyA Sheri, S Johnston
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 19, 2012
Developments in Ki67 and other biomarkers for treatment decision making in breast cancerA Sheri, M Dowsett
The British Journal of Dermatology|March 6, 2020
Trends in malignant melanoma mortality in 31 countries from 1985 to 2015D D Yang, J D Salciccioli, D C Marshall, et al.
Breast Cancer Research and Treatment|April 28, 2017
Relationship between IHC4 score and response to neo-adjuvant chemotherapy in estrogen receptor-positive breast cancerA Sheri, I E Smith, M Hills, et al.
Oncology|March 25, 2011
Is capecitabine efficacious in triple negative metastatic breast cancer?A A Kotsori, S Dolly, A Sheri, et al.
Lung Cancer (Amsterdam, Netherlands)|March 16, 2010
Histology classification is not a predictor of clinical outcomes in advanced non-small cell lung cancer (NSCLC) treated with vinorelbine or gemcitabine combinationsL Trani, J Myerson, S Ashley, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 2, 2014
Residual proliferative cancer burden to predict long-term outcome following neoadjuvant chemotherapyA Sheri, I E Smith, S R Johnston, et al.
Neurogastroenterology and Motility|November 30, 2025
Gastrointestinal Dysautonomia After Immune Checkpoint Inhibitor Therapy: A Case Series and Systematic ReviewS Sennfält, B Norton, A T Jarjis, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Clinical Oncology (Royal College of Radiologists (Great Britain))|December 11, 2012
New developments and future directions in systemic therapyA Sheri, S Johnston
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 19, 2012
Developments in Ki67 and other biomarkers for treatment decision making in breast cancerA Sheri, M Dowsett
The British Journal of Dermatology|March 6, 2020
Trends in malignant melanoma mortality in 31 countries from 1985 to 2015D D Yang, J D Salciccioli, D C Marshall, et al.
Breast Cancer Research and Treatment|April 28, 2017
Relationship between IHC4 score and response to neo-adjuvant chemotherapy in estrogen receptor-positive breast cancerA Sheri, I E Smith, M Hills, et al.
Oncology|March 25, 2011
Is capecitabine efficacious in triple negative metastatic breast cancer?A A Kotsori, S Dolly, A Sheri, et al.
Lung Cancer (Amsterdam, Netherlands)|March 16, 2010
Histology classification is not a predictor of clinical outcomes in advanced non-small cell lung cancer (NSCLC) treated with vinorelbine or gemcitabine combinationsL Trani, J Myerson, S Ashley, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 2, 2014
Residual proliferative cancer burden to predict long-term outcome following neoadjuvant chemotherapyA Sheri, I E Smith, S R Johnston, et al.
Neurogastroenterology and Motility|November 30, 2025
Gastrointestinal Dysautonomia After Immune Checkpoint Inhibitor Therapy: A Case Series and Systematic ReviewS Sennfält, B Norton, A T Jarjis, et al.
Pageof 1